Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Drug type Dual GIP/GLP-1 receptor agonist Active ingredient Tirzepatide (same as Zepbound/Mounjaro) FDA status Not FDA-approved (compounded) 2026 legality Narrow 503A patient-specific only Typical cost ~$125$449/mo, self-pay Looking for a prescription provider route
Additionally, staying hydrated by drinking an adequate amount of water (we recommend 2.5 litres) throughout the day is essential for optimal bodily functions
Thats why we take a comprehensive approachevaluating your health, lifestyle, and goals to craft a personalized plan designed for your long-term success
Ok Cancel
US$ 22.06
US$ 25.81
US$ 23.50
US$ 24.75
US$ 22.02
US$ 29.66
